Related Experiment Videos
Immunological mechanisms in metastatic spread and the antimetastatic effects of C. parvum
Abstract:
The effects of the host's immune response on metastatic spread was investigated by observing the numbers of pulmonary metastases that developed from an s.c. implant of the Lewis lung carcinoma in C57BL mice in which different cell populations had been suppressed. Macrophage function was impaired by treatment with silica (Si), cortisone acetate (CA), or trypan blue (TB). T-cell function was depressed by adult thymectomy and sublethal irradiation, or by treatment with antilymphocyte serum (ALS). Metastasis was significantly increased and phagocytic activity decreased by Si and CA, but were unaffected by TB. Thymectomy and irradiation had no effect on metastases, whereas ALS when given before, but not after tumour growth, reduced their number. The antimetastatic action of the immunopotentiating agent C. parvum was investigated in these immunologically impaired mice. It was unaffected by Si, CA or TB. However, the inhibiting effect of these agents on phagocytic activity was overcome by treatment with C. parvum. Its antimetastatic action was unaffected in mice which had been thymectomized and irradiated, but could be abrogated by ALS. However, ALS was only able to prevent this activity if given before tumour growth; it was ineffective if given after tumour growth. This study showed that metastatic spread was inversely related to phagocytic activity. The antimetastatic effect of C. parvum appears to be mediated through macrophages in concert with a subpopulation of T lymphocytes, which were considered to be necessary in the sensitization arm of the response as opposed to the effector arm of this response.
Insights
Host immune cells, particularly macrophages and T-cells, significantly influence cancer metastasis. Impaired immune function increases tumor spread, while agents like C. parvum can enhance the immune response to inhibit metastasis.
Area of Science:
- Immunology
- Cancer Metastasis Research
- Tumor Microenvironment
Background:
- The host immune response plays a critical role in cancer progression, particularly in the metastatic spread of tumors.
- Understanding the interplay between immune cells and tumor cells is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate how suppressing specific immune cell populations affects the development of pulmonary metastases from Lewis lung carcinoma in mice.
- To evaluate the antimetastatic efficacy of the immunopotentiating agent C. parvum in immunologically impaired mice.
Main Methods:
- Lewis lung carcinoma cells were implanted subcutaneously in C57BL mice.
- Macrophage function was impaired using silica (Si), cortisone acetate (CA), or trypan blue (TB).
- T-cell function was depressed via adult thymectomy and irradiation, or antilymphocyte serum (ALS).
Main Results:
- Impaired macrophage function (Si, CA) significantly increased pulmonary metastases and decreased phagocytic activity.
- T-cell suppression via thymectomy/irradiation had no effect, while ALS reduced metastases when administered before tumor growth.
- C. parvum's antimetastatic effect was maintained in mice with impaired macrophages or T-cells but was abrogated by ALS given before tumor growth.
Conclusions:
- Metastatic spread is inversely correlated with host phagocytic activity.
- The antimetastatic action of C. parvum involves macrophages and a T-lymphocyte subpopulation crucial for immune sensitization.
- Immune modulation strategies targeting macrophages and T-cells show promise for controlling cancer metastasis.